<VariationArchive RecordType="classified" VariationID="120223" VariationName="NM_005343.4(HRAS):c.187_207dup (p.Glu63_Asp69dup)" VariationType="Duplication" Accession="VCV000120223" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2016-09-08" MostRecentSubmission="2016-09-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="125817" VariationID="120223">
      <GeneList>
        <Gene Symbol="LRRC56" FullName="leucine rich repeat containing 56" GeneID="115399" HGNC_ID="HGNC:25430" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.5</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="506462" stop="554912" display_start="506462" display_stop="554912" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NT_187586.1" start="48617" stop="84552" display_start="48617" display_stop="84552" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="537521" stop="554915" display_start="537521" display_stop="554915" Strand="+" />
          </Location>
          <OMIM>618227</OMIM>
        </Gene>
        <Gene Symbol="HRAS" FullName="HRas proto-oncogene, GTPase" GeneID="3265" HGNC_ID="HGNC:5173" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.5</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="532242" stop="535576" display_start="532242" display_stop="535576" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NT_187586.1" start="61883" stop="65217" display_start="61883" display_stop="65217" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="532241" stop="535549" display_start="532241" display_stop="535549" Strand="-" />
          </Location>
          <OMIM>190020</OMIM>
          <Haploinsufficiency last_evaluated="2015-10-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HRAS">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-10-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HRAS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005343.4(HRAS):c.187_207dup (p.Glu63_Asp69dup)</Name>
      <CanonicalSPDI>NC_000011.10:533848:GTCCCGCATGGCGCTGTACTC:GTCCCGCATGGCGCTGTACTCGTCCCGCATGGCGCTGTACTC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11p15.5</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="533848" stop="533849" display_start="533848" display_stop="533849" variantLength="21" positionVCF="533848" referenceAlleleVCF="G" alternateAlleleVCF="GGTCCCGCATGGCGCTGTACTC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="533848" stop="533849" display_start="533848" display_stop="533849" variantLength="21" positionVCF="533848" referenceAlleleVCF="G" alternateAlleleVCF="GGTCCCGCATGGCGCTGTACTC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.533849_533869dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.533849_533869dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.533849_533869dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.533849_533869dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007666.1" sequenceAccession="NG_007666" sequenceVersion="1" change="g.6682_6702dup">
            <Expression>NG_007666.1:g.6682_6702dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130442.3" sequenceAccession="NM_001130442" sequenceVersion="3" change="c.187_207dup">
            <Expression>NM_001130442.3:c.187_207dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001123914.1" sequenceAccession="NP_001123914" sequenceVersion="1" change="p.Glu63_Asp69dup">
            <Expression>NP_001123914.1:p.Glu63_Asp69dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318054.2" sequenceAccession="NM_001318054" sequenceVersion="2" change="c.-133_-113dup">
            <Expression>NM_001318054.2:c.-133_-113dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005343.4" sequenceAccession="NM_005343" sequenceVersion="4" change="c.187_207dup" MANESelect="true">
            <Expression>NM_005343.4:c.187_207dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005334.1" sequenceAccession="NP_005334" sequenceVersion="1" change="p.Glu63_Asp69dup">
            <Expression>NP_005334.1:p.Glu63_Asp69dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_176795.5" sequenceAccession="NM_176795" sequenceVersion="5" change="c.187_207dup" MANEPlusClinical="true">
            <Expression>NM_176795.5:c.187_207dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_789765.1" sequenceAccession="NP_789765" sequenceVersion="1" change="p.Glu63_Asp69dup">
            <Expression>NP_789765.1:p.Glu63_Asp69dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_506" sequenceAccession="LRG_506">
            <Expression>LRG_506:g.6682_6702dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_506t1" sequenceAccession="LRG_506t1">
            <Expression>LRG_506t1:c.187_207dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_506p1" sequenceAccession="LRG_506p1" change="p.Glu63_Asp69dup">
            <Expression>LRG_506p1:p.Glu63_Asp69dup</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA267613" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="190020.0018" DB="OMIM" />
        <XRef Type="rs" ID="587777239" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005343.4(HRAS):c.187_207dup (p.Glu63_Asp69dup) AND Costello syndrome" Accession="RCV000106320" Version="3">
        <ClassifiedConditionList TraitSetID="3420">
          <ClassifiedCondition DB="MedGen" ID="C0587248">Costello syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-04-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-04-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-09-08" MostRecentSubmission="2016-09-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23335589</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3420" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4860" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Costello syndrome</ElementValue>
                <XRef ID="Costello+Syndrome/1942" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009026" DB="MONDO" />
                <XRef ID="309776008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Faciocutaneoskeletal syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FCS syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CSTLO</ElementValue>
                <XRef Type="MIM" ID="218040" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1550" />
                <XRef ID="1550" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">While the majority of individuals with Costello syndrome share characteristic findings affecting multiple organ systems, the phenotypic spectrum is wide, ranging from a milder or attenuated phenotype to a severe phenotype with early lethal complications. Costello syndrome is typically characterized by failure to thrive in infancy as a result of severe postnatal feeding difficulties; short stature; developmental delay or intellectual disability; coarse facial features (full lips, large mouth, full nasal tip); curly or sparse, fine hair; loose, soft skin with deep palmar and plantar creases; papillomata of the face and perianal region; diffuse hypotonia and joint laxity with ulnar deviation of the wrists and fingers; tight Achilles tendons; and cardiac involvement including: cardiac hypertrophy (usually typical hypertrophic cardiomyopathy), congenital heart defect (usually valvar pulmonic stenosis), and arrhythmia (usually supraventricular tachycardia, especially chaotic atrial rhythm/multifocal atrial tachycardia or ectopic atrial tachycardia). Relative or absolute macrocephaly is typical, and postnatal cerebellar overgrowth can result in the development of a Chiari I malformation with associated anomalies including hydrocephalus or syringomyelia. Individuals with Costello syndrome have an approximately 15% lifetime risk for malignant tumors including rhabdomyosarcoma and neuroblastoma in young children and transitional cell carcinoma of the bladder in adolescents and young adults.</Attribute>
                <XRef ID="NBK1507" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301680</ID>
                <ID Source="BookShelf">NBK1507</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <XRef ID="3071" DB="Orphanet" />
              <XRef ID="C0587248" DB="MedGen" />
              <XRef ID="MONDO:0009026" DB="MONDO" />
              <XRef Type="MIM" ID="218040" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="250459" SubmissionDate="2016-09-02" DateLastUpdated="2016-09-08" DateCreated="2014-04-01">
        <ClinVarSubmissionID localKey="190020.0018_COSTELLO SYNDROME" title="HRAS, 21-BP DUP, NT187_COSTELLO SYNDROME" />
        <ClinVarAccession Accession="SCV000143881" DateUpdated="2016-09-08" DateCreated="2014-04-01" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-04-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 18-year-old girl, born of consanguineous Turkish parents, with a relatively mild form of Costello syndrome (218040), Lorenz et al. (2013) identified a de novo heterozygous 21-bp duplication (c.187_207dup) in exon 3 of the HRAS gene, resulting in the duplication of amino acids 63 to 69 (E63_D69dup). Five of these residues are an integral part of the HRAS switch II domain that mediates binding of HRAS with various regulator and effector proteins. In vitro cellular functional expression studies showed that the E63_D69dup mutation increases HRAS coprecipitation with certain effector proteins, but not with PIK3CA (171834). Overexpression of the mutant protein increased steady-state phosphorylation of downstream effectors MEK1/2 and ERK1/2, but not AKT. The mutant protein had some residual response to EGF stimulus compared to constitutively active HRAS mutations. The findings indicated that this duplication mutant has a gain-of-function effect for some effectors, but this is counteracted by a normal effect on PIK3CA signaling. The patient had mildly delayed psychomotor development as a child, as well as hypertrophic cardiomyopathy, osteoporosis, coarse facial features, short stature, hyperkeratotic skin lesions, pigmentary anomalies, and mild intellectual disability. Lorenz et al. (2013) concluded that the attenuated phenotype in this patient was due to impaired regulator and effector binding of the E63_D69dup mutant.</Attribute>
              <Citation>
                <ID Source="PubMed">23335589</ID>
              </Citation>
              <XRef DB="OMIM" ID="218040" Type="MIM" />
              <XRef DB="OMIM" ID="171834" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HRAS" />
          </GeneList>
          <Name>HRAS, 21-BP DUP, NT187</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">21-BP DUP, NT187</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="190020.0018" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COSTELLO SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="250459" TraitType="Disease" MappingType="Name" MappingValue="COSTELLO SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0587248" Name="Costello syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

